Psyence Biomedical Ltd. (PBM)Healthcare | Biotechnology | Toronto, Canada | NasdaqCM
11.30 USD
+3.70
(48.684%)
⇧
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★★★☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:42 a.m. EDT
Speculative catalyst play with no earnings support; severe statistical signals indicate potential short-term downside despite last week's volatility spike. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.246368 |
| AutoETS | 0.390565 |
| AutoTheta | 1.006306 |
| AutoARIMA | 1.367407 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 60% |
| H-stat | 0.89 |
| Ljung-Box p | 0.009 |
| Jarque-Bera p | 0.001 |
| Excess Kurtosis | 1.70 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 25,914,370 |
| Beta | 0.31 |
| Previous Name | Psyence Therapeutics Corp. |
| Website | https://www.psyencebiomed.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.917631 |
| Address1 | 121 Richmond Street West |
| Address2 | Penthouse Suite, 1300 |
| All Time High | 341,015.62 |
| All Time Low | 1.92 |
| Ask | 14.22 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 14,632,940 |
| Average Daily Volume3 Month | 2,589,679 |
| Average Volume | 2,589,679 |
| Average Volume10Days | 14,632,940 |
| Beta | 0.306 |
| Bid | 9.02 |
| Bid Size | 2 |
| Book Value | 39.619 |
| City | Toronto |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 11.3 |
| Current Ratio | 8.09 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 16.9593 |
| Day Low | 11.06 |
| Display Name | Psyence Biomedical |
| Ebitda | -4,145,455 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.908 |
| Enterprise Value | -3,765,318 |
| Eps Trailing Twelve Months | -389.98 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.94322 |
| Fifty Day Average Change | 8.35678 |
| Fifty Day Average Change Percent | 2.8393326 |
| Fifty Two Week Change Percent | -91.7631 |
| Fifty Two Week High | 468.35938 |
| Fifty Two Week High Change | -457.0594 |
| Fifty Two Week High Change Percent | -0.97587323 |
| Fifty Two Week Low | 1.92 |
| Fifty Two Week Low Change | 9.38 |
| Fifty Two Week Low Change Percent | 4.885417 |
| Fifty Two Week Range | 1.92 - 468.35938 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,639,146,600,000 |
| Float Shares | 292,594 |
| Free Cashflow | -4,006,023 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 12 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.04445 |
| Held Percent Institutions | 0.01434 |
| Implied Shares Outstanding | 2,293,307 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,024-01-26 |
| Language | en-US |
| Last Fiscal Year End | 1,743,379,200 |
| Last Split Date | 1,769,990,400 |
| Last Split Factor | 16:100 |
| Long Business Summary | Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company has a strategic collaboration with PsyLabs to produce Ibogaine. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc. |
| Long Name | Psyence Biomedical Ltd. |
| Market | us_market |
| Market Cap | 25,914,370 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_698500412 |
| Most Recent Quarter | 1,759,190,400 |
| Name Change Date | 2,026-04-20 |
| Net Income To Common | -3,941,597 |
| Next Fiscal Year End | 1,774,915,200 |
| Non Diluted Market Cap | 25,914,369 |
| Open | 13.1635 |
| Operating Cashflow | -4,247,508 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 416 346 7764 |
| Pre Market Change | -0.32999992 |
| Pre Market Change Percent | -2.9203532 |
| Pre Market Price | 10.97 |
| Pre Market Time | 1,776,770,368 |
| Prev Name | Psyence Therapeutics Corp. |
| Previous Close | 7.6 |
| Price Hint | 2 |
| Price To Book | 0.2852167 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.766 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 3.7 |
| Regular Market Change Percent | 48.6842 |
| Regular Market Day High | 16.9593 |
| Regular Market Day Low | 11.06 |
| Regular Market Day Range | 11.06 - 16.9593 |
| Regular Market Open | 13.1635 |
| Regular Market Previous Close | 7.6 |
| Regular Market Price | 11.3 |
| Regular Market Time | 1,776,715,200 |
| Regular Market Volume | 40,992,111 |
| Return On Assets | -0.34442002 |
| Return On Equity | -0.74286 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 2,293,307 |
| Shares Percent Shares Out | 0.022 |
| Shares Short | 50,560 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 142,080 |
| Short Name | Psyence Biomedical Ltd. |
| Short Percent Of Float | 0.022 |
| Short Ratio | 2.83 |
| Source Interval | 15 |
| State | ON |
| Symbol | PBM |
| Total Cash | 7,149,985 |
| Total Cash Per Share | 23.871 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -389.98 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 85.19598 |
| Two Hundred Day Average Change | -73.89597 |
| Two Hundred Day Average Change Percent | -0.8673646 |
| Type Disp | Equity |
| Volume | 40,992,111 |
| Website | https://www.psyencebiomed.com |
| Zip | M5H2K1 |